Proteomic profiling identifies distinct protein patterns in acute myelogenous leukemia CD34+CD38- stem-like cells.
Acute myeloid leukemia (AML) is believed to arise from leukemic stem-like cells (LSC) making understanding the biological differences between LSC and normal stem cells (HSC) or common myeloid progenitors (CMP) crucial to understanding AML biology. To determine if protein expression patterns were dif...
Guardado en:
Autores principales: | Steven M Kornblau, Amina Qutub, Hui Yao, Heather York, Yi Hua Qiu, David Graber, Farhad Ravandi, Jorge Cortes, Michael Andreeff, Nianxiang Zhang, Kevin R Coombes |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2013
|
Materias: | |
Acceso en línea: | https://doaj.org/article/38799d6c55234a568892bf6269172951 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Targeting CD38 in acute myeloid leukemia interferes with leukemia trafficking and induces phagocytosis
por: Meike Farber, et al.
Publicado: (2021) -
Bosutinib in the management of chronic myelogenous leukemia
por: Keller-von Amsberg G, et al.
Publicado: (2013) -
Isolation and characterization of CD34+ blast-derived exosomes in acute myeloid leukemia.
por: Chang Sook Hong, et al.
Publicado: (2014) -
Spotlight on nilotinib in the treatment of chronic myelogenous leukemia
por: Harnicar S, et al.
Publicado: (2014) -
Imatinib treatment induces CD5+ B lymphocytes and IgM natural antibodies with anti-leukemic reactivity in patients with chronic myelogenous leukemia.
por: Silvia Catellani, et al.
Publicado: (2011)